INS and obesity due to melanocortin 4 receptor deficiency: Studies link obesity to a higher risk of various cancers and poorer treatment outcomes, driven by pro-inflammatory signaling, hormonal disruptions, and insulin resistance that create a tumor-friendly environment (31).